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The Editor-in-Chief and Publisher have retracted this
article [1] because the scientific integrity of the content
cannot be guaranteed. An investigation by the Publisher
found it to be one of a group of articles we have identified
as showing evidence suggestive of attempts to subvert the
peer review and publication system to inappropriately
obtain or allocate authorship. This article showed evidence
of plagiarism (most notably from the articles cited [2–4])
and authorship manipulation.
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